JPD Capital launches medicinal cannabis fund

JPD Capital launched an exclusive medicinal cannabis fund in London earlier this week.

It was launched by the founder of the UK based medicinal cannabis company Eco Equity, Jon-Paul Doran.

With investors from all over the globe, the minimum investment into the fund is £25,000.

JPD Capital aims to invest in entities varying from greenhouse to lighting, seed to cultivation, agricultural suppliers to distribution and businesses which have a role to play in the “seed to sail” journey.

“I am delighted to be launching our medicinal cannabis fund in the UK. The success of our pharmaceutical arm Eco Equity over the past 18 months shows there is appetite for investment in the industry,” Jon-Paul Doran, founder of JPD Capital, provided a comment.

As government policy on the us of medicinal cannabis in the UK begins to relax, the sector is proving highly popular to investors.

“The cannabis market is the fastest-growing market of 2019, proving its unstoppable growth and obvious attraction for investors,” the founder of JPD Capital continued.

The launch took place at the top of London’s symbolic Gherkin skyscraper and featured a panel discussion on the future of the medicinal cannabis policy in the UK.

Jon-Paul Doran said: “We want our investors to feel confident and we want our investors to see returns, as well as achieving our main aim of finding alternative and natural treatments for life-threatening illnesses.”

Over the next few months, JPD Capital aims to further invest in and diversify its portfolio, with the medicinal cannabis company Eco Equity included.

In the past year, the fund has already invested in projects located in Zimbabwe and Antigua through Eco Equity, which acquired one of five licences to cultivate cannabis for medical purposes in Zimbabwe.

Foundations have already been built and the cultivation of cannabis is anticipated to commence in the second quarter of 2020, JPD Capital said.

Meanwhile, Eco Equity was most recently granted approval for a medicinal cannabis dispensary licence in Antigua and Barbuda.

Timothy Ambrose, Chief Operating Officer of Eco Equity, also provided a comment: “The funds invested into Eco Equity in the last year have resulted in successful acquisitions of licences in Zimbabwe and Antigua. We are focused on the next stage of production and particularly in the Caribbean, we want to achieve our aim of becoming Antigua’s exclusive dispensary brand.”

“Over the coming year we will begin cultivation and by the end of the year we will be supplying the cannabis market with high grade, GMP certified CBD products,” Timothy Ambrose continued.

Despite the controversy behind it, there is evidence to suggest that cannabis does have many medical benefits.